Abstract

We previously showed conjugated linoleic acids (CLA) inhibited TNF- α-induced monocyte (THP-1) adhesion to human umbilical vein endothelial cells (HUVEC) in vitro which involved an increase in platelet activating factor (PAF). Here we show adhesion molecule (ADM) regulation by fatty acids and the differing role of nuclear factor kappa B (NF- κB) activation in HUVEC and vascular smooth muscle cells (vSMC). CLA and omega-3 long-chain polyunsaturated fatty acids (PUFA) (FA) reduced TNF-ά-induced expression of ADMs (intercellular adhesion molecule-1 (ICAM-1); vascular cell adhesion molecule-1 (VCAM-1) but not E-selectin) on HUVEC and vSMC to different extents depending on FA type and concentration, cell type and method of analysis. I κBά phosphorylation in HUVEC and vSMC and transient transfection with NF- κB-luciferase reporter plasmid (HUVEC only) indicated differential NF- κB involvement during FA modulation ( cis-9, trans-11; trans-10, cis-12 and a 50:50 mix of both CLA isomers; eicosapentaenoic acid (EPA); docosahexaenoic acid (DHA)). TNF- α-induced ADM expression in both cell types by 2–10-fold. In HUVEC, CLA t10, c12 and CLA mix (50:50 mixture of CLA c9, t11 and t10, c12) and EPA and DHA reduced ICAM-1 expression (15–35%) at 12.5, 25 and/or 50 μM. VCAM-1 expression was reduced by 25 μM t10, c12 isomer and mix; omega-3 PUFA and other concentrations of CLA and TNF- α-induced E-selectin expression were unaffected. TNF α-induced inhibitor kappa B (I κB) phosphorylation was biphasic peaking at 5 min in both cell types and 60 and 120 min in HUVEC and SMC, respectively. I κB α phosphorylation and NF- κB activity was reduced (29% and 30%, respectively) by 25 μM CLA mix. n-3 PUFA did not reduce I κB α phosphorylation or NF- κB activity but reduced ADM expression. We show that n-3 PUFA and CLA reduce expression of ADM on HUVEC and vSMC. This reflected reduced adherence of monocytes to HUVEC previously reported by our group. Reduction of ICAM-1 and VCAM-1 protein expression by n-3 PUFA was less dependent on the NF- κB pathway than reduction by CLA which reflected the parallel attenuation of NF- κB activity. This indicated involvement of other transcription factors (i.e. AP-1) in the FA regulation of ADM expression and has, to our knowledge, not been previously reported.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.